Current Funding Opportunities Update

Read in Browser Current Funding Opportunities Notice of Special Interest (NOSI): Alzheimers-Focused Administrative Supplements for NIH Grants that are Not Focused on Alzheimers Disease 05/04/2023  The participating Institutes and Centers (ICs) are inviting applications to expand existing awards that are not currently focused on Alzheimer's disease (AD) and its related dementias (ADRD) (e.g., frontotemporal dementia, Lewy body dementia, Vascular Contributions to Cognitive Impairment and Dementia (VCID), and multiple etiology dementias) to allow the research to develop such a focus. Active awards with project end dates in FY 2025 or later are eligible. The award may not be in a terminal no-cost extension or going into a no-cost extension in FY 2024. Please note that a few ICs limit no-cost extensions in the final non-competing year of an award. For that reason, it is important to contact staff at the IC supporting the award when planning the request. Brad Cooke, Ph.D. | NOT-AG-23-015 Human Liver Tissue and Hepatocytes Resource-Related Research Project (R24 Clinical Trial Not Allowed) 05/03/2023  The purpose of this Notice of Funding Opportunity (NOFO) is to support a Human Liver Tissue and Hepatocytes Research Resource (HLTHRR) program to enable the continued availability of human liver tissue and hepatocytes to biomedical researchers. The research resource is expected to facilitate the procurement and preservation of human liver tissue and hepatocytesas well as the distribution of these materials to qualified biomedical researchers. Applications focused on animal liver and/or hepatocytes studies will not be considered responsive to this NOFO. Martha Garcia Ph.D.; Jose Serrano M.D., Ph.D. | RFA-DK-23-012 Emergency Award: RADx-UP Dissemination and Implementation (D and I) Research on COVID-19 Testing Interventions among Underserved and Vulnerable Populations (R01 Clinical Trial Optional) 05/02/2023  The purpose of this Notice of Funding Opportunity (NOFO) is to support dissemination and implementation (D and I) research focused on increasing access to and uptake of coronavirus disease 2019 (COVID-19) testing interventions with the goal of reducing COVID-19 disparities and promoting health equity among underserved and vulnerable populations. This NOFO will support D and I research on how evidence-based practices, interventions, and policies are effectively translated to and used in real-world settings. Projects may evaluate the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, or seek to understand the de-implementation of practices that are ineffective, low-value, or inequitable. Interventions developed through the Rapid Acceleration of Diagnostics Underserved Populations (RADx-UP) initiative are encouraged, but not required. The funding for this program is provided from the American Rescue Plan Act of 2021, Public Law 117-2. Jenna Norton, Ph.D., MPH;Shavon Artis Dickerson, Dr.P.H., M.P.H.;Raquel Greer, M.D., M.H.S. | RFA-OD-23-051 Emergency Award: Novel Insights through Cross-Site Analyses of Existing RADx-UP Data (R21 Clinical Trial Not Allowed) 05/02/2023  This Notice of Funding Opportunity (NOFO) will support analyses of existing RADx-UP data by proposing novel questions related to SARS-CoV-2 testing and health disparities. These projects will explore important questions focused on COVID-19 testing access and uptake, factors affecting testing and related COVID-19 outcomes, and meta-analyses of specific COVID-19 response and intervention approaches within and across populations. Jenna Norton, Ph.D., MPH; Shavon Artis Dickerson, Dr.P.H., M.P.H.; Raquel Greer, M.D., M.H.S. | RFA-OD-23-050 View All Funding Opportunities

To unsubscribe, update your password, or change your email address visit our Subscriber Preference Page. For any questions or problems with this subscription service, please visit the Subscriber Help Center.

---

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · 1 Information Way, Bethesda, MD 20892 · 1-800-860-8747